Effect of early statin treatment in patients with cardiogenic shock complicating acute myocardial infarction

Korean Circulation Journal

Volumn 43, Issue 2, 2013, Pages 100-109

  Sim, Doo Sun ^a   Jeong, Myung Ho ^a   Cho, Kyung Hoon ^a   Ahn, Youngkeun ^a   Kim, Young Jo ^b   Chae, Shung Chull ^c   Hong, Taek Jong ^d   Seong, In Whan ^e   Chae, Jei Keon ^f   Kim, Chong Jin ^g   Cho, Myeong Chan ^h   Rha, Seung Woon ⁱ   Bae, Jang Ho ^j   Seung, Ki Bae ^k   Park, Seung Jung ^l   Kim, Jong Hyun ^m   Hur, Seung Ho ^m   Rhew, Jae Young ^m   Kim, Doo Il ^m   Chae, In Ho ^m   Yoon, Jung Han ^m   Koo, Bon Kwon ^m   Kim, Byung Ok ^m   Lee, Myoung Yong ^m   Kim, Kee Sik ^m   Hwang, Jin Yong ^m   Oh, Seok Kyu ^m   Lee, Nae Hee ^m   Jeong, Kyoung Tae ^m   Tahk, Seung Jea ^m   Park, Keum Soo ^m   Han, Kyoo Rok ^m   Ahn, Tae Hoon ^m   Kim, Moo Hyun ^m   Chung, Wook Sung ^m   Yang, Ju Young ^m   Rhim, Chong Yun ^m   Gwon, Hyeon Cheol ^m   Park, Seong Wook ^m   Koh, Young Youp ^m   Joo, Seung Jae ^m   Kim, Soo Joong ^m   Jin, Dong Kyu ^m   Cho, Jin Man ^m   Jang, Yang Soo ^m   Cho, Jeong Gwan ^m   more..

^a Chonnam National University Medical School   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

^e Chungnam National University College of Medicine   (South Korea)

^f Chonbuk National University Medical School   (South Korea)

^g Kyung Hee University Hospital   (South Korea)

^h Chungbuk National University College of Medicine   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Konyang University College of Medicine   (South Korea)

^k The Catholic University of Korea College of Medicine   (South Korea)

^l University of Ulsan College of Medicine   (South Korea)

^m NONE

more..

Author keywords

Angioplasty; Myocardial infarction; Shock

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; REVASCULARIZATION; TREATMENT OUTCOME;

EID: 84875871111     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2013.43.2.100     Document Type: Article

References (28)

1. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation 2008;118:2596-648.
2. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
3. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
4. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2011;123:2022-60.
5. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-9.
6. TRIUMPH Investigators, Alexander JH, Reynolds HR, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 2007;297:1657-66.
7. Sim DS, Kim JH, Jeong MH. Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea. Korean Circ J 2009;39:297-303.
8. Sim DS, Jeong MH, Kang JC. Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry. J Cardiol 2010;56:1-7.
9. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
10. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999;150:327-33. (Pubitemid 29383480)
11. Gu XS, Rosenbaum PR. Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms. J Comput Graph Stat 1993;2:405-20.
12. Arntz HR, Agrawal R, Wunderlich W, et al. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol 2000;86:1293-8.
13. Aronow HD, Novara GM, Lauer MS, et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med 2003;163:2576-82. (Pubitemid 37464415)
14. Fonarow GC, Wright RS, Spencer FA, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005;96:611-6. (Pubitemid 41207298)
15. Muhlestein JB, Home BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 2001;87:257-61. (Pubitemid 32144862)
16. Li YH, Wu HL, Yang YH, Tsai HS, Chao TH. Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndrome. Int Heart J 2007;48:677-88.
17. Kim MC, Ahn Y, Cho KH, et al. Early statin therapy within 48 hours decreased one-year major adverse cardiac events in patients with acute myocardial infarction. Int Heart J 2011;52:1-6.
18. Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 2004;140:857-66.
19. Garot P, Bendaoud N, Lefèvre T, Morice MC. Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock. Euro-Intervention 2010;6:350-5.
20. Schmidt H, Hennen R, Keller A, et al. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med 2006;32:1248-51. (Pubitemid 44232422)
21. Pruefer D, Makowski J, Schnell M, et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002;106:2104-10. (Pubitemid 35192817)
22. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9. (Pubitemid 36019638)
23. Schmidt H, Müller-Werdan U, Hoffmann T, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 2005;33:1994-2002. (Pubitemid 41306521)
24. Schmidt H, Hoyer D, Hennen R, et al. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit Care Med 2008;36:967-70.
25. Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004;109:2560-5. (Pubitemid 38720557)
26. Merx MW, Liehn EA, Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation 2005;112:117-24. (Pubitemid 40962577)
27. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004;110:880-5. (Pubitemid 39096018)
28. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006;367:413-8. (Pubitemid 43184262)